In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
GDP: Growth rate revised to 9.1 percent for 2021-22, to grow at 7% in 2022-23
The government has revised the economic growth rate for the year 2021-22 from 8.7 percent to 9.1
Voice of Global South Summit: Prime Minister Narendra Modi on Thursday addressed the inaugural se
Delhi Police is trying to find the concrete evidence against Aftab Amin Poonawalla, accused of br
Kremlin (Russian presidential office) officials said Ukraine targeted the Crimean peninsula with
There is a lot of anger among the local people due to the killing of innocent people by terrorist
Shooting at Mall of America: 3 killed, 2 injured; Armed civilian shot at the attacker and killed him
There has been a shooting at a mall in the US state of Indiana. 3 people have died in this incide
Madarsa Survey: 8496 unrecognized madrassas found in UP, a maximum 557 in Moradabad
Madarsa Survey in UP: The survey of unrecognized madrasas in Uttar Pradesh has now been completed
The tenure of the committee constituted for the Waqf Amendment Bill was extended till the last da
Monsoon rains have wreaked havoc in many states of North India. Delhi, Haryana, Punjab, and Himac
Weather Update Today: According to the India Meteorological Department (IMD), there is a possibil
